Legal Advantage Investments, Inc. Heska Corp Transaction History

Legal Advantage Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$156.0 - $265.78 $70,200 - $119,600	-450 Reduced 1.62%	27,248 $4.96 Million
Q3 2021 Oct 25, 2021	SELL	$228.69 - $274.2 $91,476 - $109,680	-400 Reduced 1.42%	27,698 $7.16 Million
Q2 2021 Jul 26, 2021	SELL	$169.89 - $231.37 $8,494 - $11,568	-50 Reduced 0.18%	28,098 $6.46 Million
Q1 2021 May 06, 2021	SELL	$143.93 - $207.3 $28,786 - $41,460	-200 Reduced 0.71%	28,148 $4.74 Million
Q4 2020 Jan 28, 2021	BUY	$96.1 - $151.18 $2.72 Million - $4.29 Million	28,348 New	28,348 $4.13 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Legal Advantage Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Legal Advantage Investments, Inc. with notifications on news.